论文信息 - Randomized phase 3 study of carfilzomib or bortezomib with melphalan-prednisone for transplant-ineligible , NDMM patients Running title : KMP vs VMP for newly diagnosed multiple myeloma - 字舞流文

Randomized phase 3 study of carfilzomib or bortezomib with melphalan-prednisone for transplant-ineligible , NDMM patients Running title : KMP vs VMP for newly diagnosed multiple myeloma

M. Dimopoulos | J. H. Lee | P. Moreau | B. Paiva | T. Facon | J. San-Miguel | L. Qiu | A. Jurczyszyn | R. Niesvizky | A. Zahlten-Kumeli | L. Pour | Román | Z. Klippel | Hájek | Muhtarjan | Osman | Zandra K. Klippel